Dexmethylphenidate: Difference between revisions

Nav

[checked revision]

@@ Line 61: / Line 61: @@
 * <effect ref="seizure">Caution in epilepsy.</effect>
 * <effect ref="withdrawal">Fatigue, rebound hyperactivity, dysphoria on dose offset.</effect>
-| contraindications = * Hypersensitivity to dexmethylphenidate or methylphenidate
-* Concurrent MAOI use, or within 14 days of MAOI discontinuation
-* Symptomatic cardiovascular disease, advanced atherosclerosis, moderate–severe hypertension, recent MI
-* Hyperthyroidism
-* Glaucoma
-* Pheochromocytoma
-* Severe anxiety, tension, or agitation
-* '''Relative:''' Tourette syndrome / tic disorders, history of substance use disorder, bipolar disorder, psychotic disorders, structural cardiac abnormalities
 | interactions      = * '''MAOIs''' — hypertensive crisis risk; contraindicated within 14 days
 * '''Tricyclic antidepressants''' — possible elevation of TCA levels; additive cardiovascular effects